Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
Abstract Aims Acute decompensated heart failure (ADHF) is generally treated by decongestion using diuretic therapy. However, the use of loop diuretics is associated with increased cardiac sympathetic nerve activity (CSNA). We aimed to evaluate the effect of adjunctive tolvaptan therapy on CSNA in AD...
Saved in:
| Main Authors: | Shunsuke Tamaki, Takahisa Yamada, Takashi Morita, Yoshio Furukawa, Masato Kawasaki, Atsushi Kikuchi, Tsutomu Kawai, Masahiro Seo, Makoto Abe, Jun Nakamura, Kyoko Yamamoto, Kiyomi Kayama, Masatsugu Kawahira, Kazuya Tanabe, Kunpei Ueda, Takanari Kimura, Daisuke Sakamoto, Yuto Tamura, Takeshi Fujita, Masatake Fukunami |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-06-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.12690 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Importance of early use of tolvaptan in hyponatremic acutely decompensated heart failure patients, a retrospective study
by: Rarsari Soerarso, et al.
Published: (2025-01-01) -
Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5
by: Akinari Sekine, et al.
Published: (2025-06-01) -
Severe tolvaptan-associated hyperglycemia: a case report
by: Huihuan Sun, et al.
Published: (2025-07-01) -
Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
by: Matt Gittus, et al.
Published: (2025-02-01) -
Post-hepatectomy tolvaptan-induced hypernatremia in a hepatocellular carcinoma patient with cirrhosis: a case report
by: Hiroya Iida, et al.
Published: (2020-03-01)